Background/Aims: Colorectal cancer (CRC) with microsatellite instability (MSI) has a better prognosis than CRC with microsatellite stable (MSS). Recent studies have reported biological differences according to tumor location in CRC. In this study, we investigated the clinical significance of MSI in patients with right-sided CRC. Methods: The medical records of 1,009 CRC patients diagnosed at our institute between October 2004 and December 2016 with MSI test results were retrospectively reviewed. The long-term outcomes of CRC patients with MSI were assessed with respect to tumor location using Kaplan-Meier curves and Cox regression models. Results: The median follow-up duration for all 1,009 study subjects was 25 months (interquartile range, 15-38). One hundred twenty-four of the study subjects had MSI (12.3%) and 250 had right-sided CRC (24.8%). The patients with MSI and right-sided CRC had better disease-free survival (DFS) than those with MSS as determined by the log-rank test (p=0.013), and this result was significant in females (p=0.035) but not in males with right-sided CRC. Multivariate Cox regression analysis showed MSS significantly predicted poor DFS in patients with right-sided CRC (hazard ratio 3.97, 95% CI 1.30-12.15, p=0.016) and in female patients (hazard ratio 4.69, 95% CI 1.03-21.36, p=0.045). Conclusions: The study shows MSI is a useful predictor of DFS in patients with right-sided CRC, especially in female patients. (Korean J Gastroenterol 2019;73:159-166) 
INTRODUCTION
Colorectal cancer (CRC) is the third most common tumor in men and the second most common tumor in women worldwide. 1 According to World Health Organization data, the incidence of CRC in Korea is the highest in the world with an age-standardized death rate of 45 per 100,000. 2 Although the 5-year survival rate of CRC has increased over the past few years, this disease is still the third leading cause of cancer-related death worldwide. 3 CRC is a heterogeneous complex of diseases that results from accumulations of distinct genetic and epigenetic alterations. SUBJECTS AND METHODS
Patients
The medical records of patients diagnosed with CRC at 
Assessment of DFS according to MSI status
For right-sided CRC, patients with MSI (MSI-L or MSI-H) had a significantly higher mean DFS than patients with MSS (p=0.013), but this was not observed in left-sided CRC (p=0.846) (Fig. 1) . Baseline characteristics of patients with right-sided CRC according to MSI status are summarized in (Fig. 2) . However, no significant difference was observed between the mean DFSs of male patients with right-or left-sided CRC and MSI or MSS (Fig. 3) . Furthermore, no significant association was observed between tumor stage and microsatellite status or CRC sidedness (Fig. 4) .
Factors affecting long-term outcomes
Cox regression analysis was used to identify clinicopatho- (Table 4) . No such relations were observed for male patients with right-sided CRC.
DISCUSSION
This study shows, especially for women, right-sided CRC patients with MSI have a better prognosis than right-sided patients with MSS and that MSI is a useful prognostic factor of long-term outcome in right-sided CRC. Although MSI is found in only ~15% of sporadic CRC patients, it is considered a good prognostic marker in CRC and a predictable marker for immunotherapy. 7, 9, 14, 15 According to the National Comprehensive Cancer Network guidelines, stage II CRC patients with MSI-H may have a good prognosis and do not benefit from 5-fluorouracil-based adjuvant chemotherapy. 16 Conversely, it is recommended adjuvant chemotherapy be considered for stage II CRC patients with MSI-L or MSS. 16 In the present study, subanalysis was performed on pa- Some studies have reported left-sided CRC has a better prognosis than right-sided CRC, because left-sided CRC can be diagnosed at an early stage by sigmoidoscopy or by apparent symptoms, such as rectal bleeding. [19] [20] [21] Patients with right-sided CRC are more likely to be older, female, be diagnosed with more advanced disease, and to have poorly differentiated tumors. 21 A systemic review and meta-analysis showed patients with right-sided CRC had a significantly poorer prognosis than left-sided CRC, and it was suggested right-sided CRC patients should be treated differently from left-sided CRC patients. 22 In the present study, we investigated prognostic factors in patients with right-sided CRC, and interestingly, we noticed the proportion of poorly differentiated or mucinous tumors in MSI was significantly greater than in MSS ( Table 2 ), and that the long-term outcomes of patients with MSI were better than those of patients with MSS.
Furthermore, we found MSI usefully predicted long-term outcomes in patients with right-sided CRC.
Recently, gender-associated differences in CRC have attracted considerable interest. Some have reported epidermal growth factor receptor signaling in liver differs between female and male mice, and suggested this difference may influence the prognosis of CRC patients with liver metastasis. 23, 24 In a retrospective cohort study of 39,325 CRC patients that underwent surgical resection, it was shown women presented more emergently and at an older age and had a longer adjusted survival than men. 25 In addition, a recent meta-analysis concluded female CRC patients had significantly better overall survival and cancer-specific survival rates than male CRC patients. 26 In the present study, female right-sided CRC patients with MSI had a significantly better prognosis than those with MSS. Although further studies are needed, these results suggest that gender significantly affects the long-term outcomes of CRC patients.
This study had some limitations that warrant mention. First, it is limited by its retrospective, single center design, which means selection bias could not be avoided, though we did try to minimize bias by repeatedly reviewing medical records.
Second, the male to female ratios of patients with right-sided and left-sided CRC were significantly different. To address this shortcoming, we performed sub-group analysis by gender in patients with right-sided and left-sided CRC.
In conclusion, the present study shows MSI usefully predicts DFS in patients with right-sided CRC, especially in female patients. Based on the results of this study, we suggest MSI, tumor location, and gender are important considerations during initial assessments in terms of the prediction of long-term outcomes.
